Dr. Chris Larsen joined Arkana in 2009 after graduating from medical school at the University of Arkansas for Medical Sciences, completing anatomic pathology residency at Emory University, and completing renal pathology fellowship at Arkana Laboratories. Dr. Larsen developed and directs our molecular/genomics lab and directs our researchactivities as well as being instrumental in many facets of practice management at Arkana Laboratories. He is an avid researcher who has been instrumental in explaining the complexities of APOL1 gene risk variants and their effects on the kidney as well as describing a previously undiscovered kidney disease (membranous-like glomerulopathy with masked IgG kappa deposits). He has published extensively in the areas of membranous glomerulopathy, APOL1-related kidney disease, new and esoteric kidney disease, LECT2 amyloidosis, and monoclonal gammopathy of renal significance. When asked, Dr. Larsen says his favorite part of working at Arkana is “having the opportunity to engage in interesting research.” In his free time, Dr. Larsen is an avid outdoorsman who enjoys spending time fly fishing and hiking with his wife and children.
At Arkana Laboratories, we are blessed to work with such a capable and inquisitive pathologist who works diligently to find answers to the most pressing questions in the field of nephrology. And, we couldn’t imagine an Arkana Laboratories without his leadership and dedication to fighting renal disease.
Quick note: This post is to be used for informational purposes only and does not constitute medical or health advice. Each person should consult their own doctor with respect to matters referenced. Arkana Laboratories assumes no liability for actions taken in reliance upon the information contained herein.